The promise of AI in biotech and in oncology is vast. Lately, AI utilization in the health industry has seen signs of a market correction to the point where we wondered whether we were in an AI bubble about to burst. The experts we talked to tempered our fears leaning toward the explanation of ...
Over the past 30 years, there have been significant advancements in therapies and the in clinical acquisition and measurement of medical images. However, the tools and infrastructure used in clinical trial imaging workflows have largely remained unchanged [1].
Various human, operational, and tec...
July 23rd, 2024 | Chicago, IL: Yunu, a provider of medical research technology and services to life sciences companies and clinical research environments, hosted a recent panel at the Association for American Cancer Institutes’ (AACI) Cancer Research Innovation (CRI) symposium that ...
May 8, 2024—Cary, NC: Yunu, creator of a first-of-kind clinical trial imaging workflow, reading, and data management platform, is extending the reach of investigator-initiated trials (IITs) into broader and more diverse communities while harmonizing trial data on its unified cloud-based platfor...
CARY, N.C., April 10, 2024 (Newswire.com) - Yunu, a leading provider of clinical trial imaging workflow and data management solutions, proudly announces the addition of Dr. Scott Bradfield, a renowned leader in pediatric oncology, as the latest in a line of highly distinguished strategic a...
Clinical trials are an essential part of developing and validating new oncology therapies. They can bring incredible opportunities for survival to patients who are not responding to traditional treatment. Unfortunately, most trials today are limited to a few select hospitals. They’re rarely found at...
